Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
Poster

Poster

Combining Machine Learning with Grating-Coupled Interferometry to identify novel BRPF1b inhibitors

At the forefront of the Hit identification paradigmWe report the development of a new hit identification workflow combining an AI-driven virtual screen with cutting-edge biophysicsical techniques. Its application to the BRPF1b bromodomain enabled the rapid identification of micromolar binders with favourable in vitro ADMET parameters, from a virtual collection of nearly 25 million commercial compounds. Besides the excellent hit rate demonstrated with BRPF1b, our workflow provides full binding kinetics and predicts ligand binding topologies without the need to acquire new ligand- protein structures, hence not only accelerating hit identification campaigns, but also all subsequent stages of the drug discovery process.

Alternatively, search our entire resource library below

Show filters
View all
Category one
Category two
Category three
Category four
Search
Clear
Resource type
Clear
Related service line
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 items